JP2001294524A5 - - Google Patents

Download PDF

Info

Publication number
JP2001294524A5
JP2001294524A5 JP2000110859A JP2000110859A JP2001294524A5 JP 2001294524 A5 JP2001294524 A5 JP 2001294524A5 JP 2000110859 A JP2000110859 A JP 2000110859A JP 2000110859 A JP2000110859 A JP 2000110859A JP 2001294524 A5 JP2001294524 A5 JP 2001294524A5
Authority
JP
Japan
Prior art keywords
component
acetaminophen
solid preparation
aspartame
content
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000110859A
Other languages
English (en)
Other versions
JP2001294524A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2000110859A priority Critical patent/JP2001294524A/ja
Priority claimed from JP2000110859A external-priority patent/JP2001294524A/ja
Publication of JP2001294524A publication Critical patent/JP2001294524A/ja
Publication of JP2001294524A5 publication Critical patent/JP2001294524A5/ja
Pending legal-status Critical Current

Links

Description

【特許請求の範囲】
【請求項５】 成分（ａ）のアスパルテームの配合量が、成分（ｃ）のアセトアミノフェンに対して０．１〜５０質量％である請求項１〜４のいずれか１項に記載の内服固形製剤。
【請求項６】 成分（ｂ）の酸味を呈する物質の配合量が、成分（ｃ）のアセトアミノフェンに対して０．１〜５００質量％である請求項１〜４のいずれか１項に記載の内服固形製剤。
JP2000110859A 2000-04-12 2000-04-12 アセトアミノフェン配合内服固形製剤 Pending JP2001294524A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000110859A JP2001294524A (ja) 2000-04-12 2000-04-12 アセトアミノフェン配合内服固形製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000110859A JP2001294524A (ja) 2000-04-12 2000-04-12 アセトアミノフェン配合内服固形製剤

Publications (2)

Publication Number Publication Date
JP2001294524A JP2001294524A (ja) 2001-10-23
JP2001294524A5 true JP2001294524A5 (ja) 2007-05-24

Family

ID=18623296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000110859A Pending JP2001294524A (ja) 2000-04-12 2000-04-12 アセトアミノフェン配合内服固形製剤

Country Status (1)

Country Link
JP (1) JP2001294524A (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0608928A2 (pt) * 2005-03-24 2010-02-17 Daiichi Sankyo Co Ltd composição farmacêutica
DE102008004893A1 (de) * 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
CA2732018C (en) 2008-07-31 2017-07-04 Takeda Pharmaceutical Company Limited Solid pharmaceutical composition
JP5579066B2 (ja) * 2008-09-05 2014-08-27 第一三共ヘルスケア株式会社 有効成分が境界を有してなる医薬固形製剤
UY32126A (es) 2008-09-25 2010-04-30 Takeda Pharmaceutical Composición farmacéutica sólida
JP5858486B2 (ja) * 2012-05-11 2016-02-10 塩野義製薬株式会社 アスコルビン酸、スクラロースおよびアスパルテームを含有する固形製剤
JP2018154598A (ja) * 2017-03-21 2018-10-04 株式会社明治 アミノ酸含有顆粒およびその製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6348210A (ja) * 1986-08-19 1988-02-29 Freunt Ind Co Ltd 易溶性顆粒
JPH0256416A (ja) * 1988-08-19 1990-02-26 Daikyo Yakuhin Kogyo Kk 苦味を抑えた顆粒剤
JPH02221232A (ja) * 1989-02-23 1990-09-04 Wakoudou Kk のみやすい医薬組成物
JPH06287144A (ja) * 1993-02-03 1994-10-11 Takeda Chem Ind Ltd かぜ薬製剤
JP2000103746A (ja) * 1994-10-27 2000-04-11 Takeda Chem Ind Ltd 成形物およびその製造方法

Similar Documents

Publication Publication Date Title
JP2003520232A5 (ja)
DE60205870D1 (de) Orale pharmazeutische zusammensetzung aus cefpodoxim-proxetil
JP2003503454A5 (ja)
JP2002541233A5 (ja)
JP2002542342A5 (ja)
JP2004523498A5 (ja)
JP2004529078A5 (ja)
JP2008516004A5 (ja)
RU2695274C3 (ru) Новые композиции и способы их стабилизации
BR0108947A (pt) Método para preparação e citalopram; intermediário e sua composição farmacêutica
JO2493B1 (en) New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses
DE60336225D1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
JP2000159790A5 (ja)
JP2002088226A5 (ja)
JP2003513990A5 (ja)
JP2001294524A5 (ja)
JP2002012712A5 (ja)
DE60331051D1 (de) Neue atorvastatinsalze und pharmazeutische zusammensetzungen, die diese enthalten
JP2001513504A5 (ja)
JP2002114686A5 (ja)
JP2002509169A5 (ja)
DE60236025D1 (de) Pharmazeutische zusammensetzung enthaltend l-arginin
GB0212410D0 (en) Organic compounds
JP2003519690A5 (ja)
JP2005535635A5 (ja)